Literature DB >> 15354112

Primary closure for postoperative mediastinitis in children.

Richard G Ohye1, Robert B Maniker, Holly L Graves, Eric J Devaney, Edward L Bove.   

Abstract

OBJECTIVES: Mediastinitis affects approximately 1% of children undergoing median sternotomy. Conventional therapy involves debridement followed by open wound care with delayed closure, days to weeks of closed suction or antimicrobial irrigation, and vacuum-assisted closure or muscle flap closure. We hypothesized that primary closure without prolonged suction or irrigation is an effective, less traumatic treatment for mediastinitis in children.
METHODS: From January 1986 to July 2002, 6705 procedures involving median sternotomy were performed at the C. S. Mott Children's Hospital, resulting in 57 cases of mediastinitis (0.85%). Cases were divided into 2 groups, with 42 cases treated with primary closure and 15 cases treated with delayed or muscle flap closure. The 42 cases of primary closure comprised the primary study group of this institutional review board-approved, retrospective analysis. Patient demographics, surgical variables, mediastinitis-related parameters, and outcomes were evaluated.
RESULTS: One patient had recurrent mediastinitis for an overall infection eradication rate of 97% (40/41). Three patients (7%) required re-exploration for suspected ongoing infection. Of these re-explorations, 1 patient had evidence of continued mediastinitis. The remaining 2 patients with sepsis of unclear cause had no clinical or culture evidence of recurrent infection. One of these patients ultimately died of sepsis without active mediastinitis for a hospital survival of 97% (41/42). No significant differences could be detected between the treatment successes and failures in this small cohort of patients.
CONCLUSIONS: Simple primary closure is an effective means to treat selected cases of postoperative mediastinitis in children. The results compare favorably with other more lengthy or debilitating treatments.

Entities:  

Mesh:

Year:  2004        PMID: 15354112     DOI: 10.1016/j.jtcvs.2004.04.023

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  7 in total

1.  Topical negative pressure for the treatment of neonatal post-sternotomy wound dehiscence.

Authors:  J Hardwicke; H Richards; J Jagadeesan; T Jones; R Lester
Journal:  Ann R Coll Surg Engl       Date:  2012-01       Impact factor: 1.891

2.  Continuous infusion of nafcillin for sternal osteomyelitis in an infant after cardiac surgery.

Authors:  Chad A Knoderer; Jennifer L Morris; Elaine G Cox
Journal:  J Pediatr Pharmacol Ther       Date:  2010-01

3.  Mediastinitis in pediatric cardiac surgery: Prevention, diagnosis and treatment.

Authors:  Yves Durandy
Journal:  World J Cardiol       Date:  2010-11-26

4.  Successful Salvage of an Extracardiac Fontan in the Setting of Purulent Mediastinitis using Antibiotic-Impregnated Beads.

Authors:  Matthew T Coghill; Gonzalo A Wallis; Paul M Kirshbom; Thomas S Maxey
Journal:  J Pediatr Intensive Care       Date:  2018-02-06

Review 5.  V.A.C. Therapy in the management of paediatric wounds: clinical review and experience.

Authors:  Mona Baharestani; Ibrahim Amjad; Kim Bookout; Tatjana Fleck; Allen Gabriel; David Kaufman; Shannon Stone McCord; Donald C Moores; Oluyinka O Olutoye; Jorge D Salazar; David H Song; Steven Teich; Subhas Gupta
Journal:  Int Wound J       Date:  2009-08       Impact factor: 3.315

6.  Mediastinitis in pediatric cardiac surgery: treatment and cost-effectiveness in a low-income country.

Authors:  V L Vida; J Leon-Wyss; A Larrazabal; S Cruz; A R Castaneda
Journal:  Pediatr Cardiol       Date:  2007-03-05       Impact factor: 1.655

Review 7.  Extracardiac Complications in Intensive Care Units after Surgical Repair for Congenital Heart Disease: Imaging Review with a Focus on Ultrasound and Radiography.

Authors:  Takahiro Hosokawa; Saki Shibuki; Yutaka Tanami; Yumiko Sato; Yoshihiro Ko; Koji Nomura; Eiji Oguma
Journal:  J Pediatr Intensive Care       Date:  2020-09-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.